Posttransplant anemia in solid organ recipients (Q37715193)

22 August 2017

1 reference

title

Posttransplant anemia in solid organ recipients (English)

1 reference

22 August 2017

Christopher D Blosser

series ordinal

1

1 reference

PubMed ID

20303457

22 August 2017

Roy D Bloom

series ordinal

2

1 reference

22 August 2017

1 April 2010

1 reference

22 August 2017

Transplantation Reviews

1 reference

22 August 2017

24

1 reference

22 August 2017

2

1 reference

22 August 2017

89-98

1 reference

Posttransplantation anemia at 12 months in kidney recipients treated with mycophenolate mofetil: risk factors and implications for mortality

22 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

The effects of pre- and post-transplant anemia on 1-year survival after cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Predictive factors for anemia six and twelve months after orthotopic liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Late post-transplant anemia in adult renal transplant recipients. An under-recognized problem?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Prevalence and management of anemia in renal transplant recipients: a European survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Anemia: A Continuing Problem Following Kidney Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Anemia after kidney transplantation is not completely explained by reduced kidney function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Level of renal function and serum erythropoietin levels independently predict anaemia post-renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Current target ranges of mycophenolic acid exposure and drug-related adverse events: a 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Mycophenolic acid 12-h trough level monitoring in renal transplantation: association with acute rejection and toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Anemia in children after transplantation: etiology and the effect of immunosuppressive therapy on erythropoiesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Tacrolimus/sirolimus versus tacrolimus/mycophenolate in kidney transplantation: improved 3-year graft and patient survival in recent era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Sirolimus interferes with iron homeostasis in renal transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Comparative effects of sirolimus and mycophenolate mofetil on erythropoiesis in kidney transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Anemia after late introduction of sirolimus may correlate with biochemical evidence of a chronic inflammatory state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Risk factors for cardiovascular events after successful renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Anemia is associated with mortality in kidney-transplanted patients--a prospective cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

A prospective study of anaemia and long-term outcomes in kidney transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Reduced hemoglobin after heart transplantation is no independent risk factor for survival but is associated closely with impaired renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Increasing hematocrit reduces early posttransplant cardiovascular risk in diabetic transplant recipients1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

The impact of hemoglobin levels on patient and graft survival in renal transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Epidemiology of heart failure in a community-based study of subjects aged > or = 57 years: incidence and long-term survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

The interaction between heart failure and other heart diseases, renal failure, and anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

A Report of the Lisbon Conference on the Care of the Kidney Transplant Recipient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Effects of recombinant human erythropoietin on HLA sensitization and cell mediated immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Negative effects of anemia on quality of life and its improvement by complete correction of anemia by administration of recombinant human erythropoietin in posttransplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Quality of life of adolescents with end-stage renal disease and kidney transplant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10 g/dL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Correction of anemia with epoetin alfa in chronic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Erythropoietin therapy may retard progression in chronic renal transplant dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Negative impact of one-year anemia on long-term patient and graft survival in kidney transplant patients receiving calcineurin inhibitors and mycophenolate mofetil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

Impact of anemia after renal transplantation on patient and graft survival and on rate of acute rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.006

10.1016/J.TRRE.2010.01.006

7 January 2021

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20303457